Expression of the LXRα protein in human atherosclerotic lesions

被引:25
作者
Watanabe, Y
Jiang, SY
Takabe, W
Ohashi, R
Tanaka, T
Uchiyama, Y
Katsumi, K
Iwanari, H
Noguchi, N
Naito, M
Hamakubo, T
Kodama, T
机构
[1] Univ Tokyo, Lab Syst Biol & Med, Res Ctr Adv Sci & Technol,Dept Syst Biol & Med, Meguro Ku, Tokyo 1538904, Japan
[2] Kowa Co Ltd, Div Pharmaceut, Tokyo New Drug Res Labs 2, Dept Immunol Res, Tokyo, Japan
[3] Niigata Univ, Grad Sch Med & Dent Sci, Div Cellular & Mol Pathol, Dept Cellular Funct, Niigata, Japan
[4] Perseus Prote Inc, Tokyo, Japan
关键词
LXR alpha; atherosclerosis; macrophages; monoclonal antibody;
D O I
10.1161/01.ATV.0000154489.53077.4e
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective - Liver X - activated receptor alpha ( LXR alpha) regulates multiple genes controlling cholesterol metabolism and transport. To clarify its role in atherogenesis, we established a monoclonal antibody recognizing native human LXRalpha protein and studied the expression pattern in human atherosclerotic lesions. Methods and Results - A novel monoclonal antibody PPZ0412 was raised against the ligand-binding domain of LXRalpha, which can be used for immunostaining of human LXRalpha protein. LXRalpha protein was detected in the nucleus of macrophages in the liver, spleen, or lung and also in hepatocytes and adipocytes. In atherosclerotic lesions, the LXRalpha protein was detected in macrophages positive for scavenger receptor class A and/or CD68. Conclusions - In the human body, the LXRalpha protein is highly expressed in macrophage lineage cells and foam cells in atherosclerotic lesions and is identified as a target for intervention in atherosclerotic disease.
引用
收藏
页码:622 / 627
页数:6
相关论文
共 26 条
  • [1] Expression of the liver X receptor α and β in embryonic and adult mice
    Annicotte, JS
    Schoonjans, K
    Auwerx, J
    [J]. ANATOMICAL RECORD PART A-DISCOVERIES IN MOLECULAR CELLULAR AND EVOLUTIONARY BIOLOGY, 2004, 277A (02): : 312 - 316
  • [2] A NOVEL ORPHAN RECEPTOR-SPECIFIC FOR A SUBSET OF THYROID HORMONE-RESPONSIVE ELEMENTS AND ITS INTERACTION WITH THE RETINOID/THYROID HORMONE-RECEPTOR SUBFAMILY
    APFEL, R
    BENBROOK, D
    LERNHARDT, E
    ORTIZ, MA
    SALBERT, G
    PFAHL, M
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1994, 14 (10) : 7025 - 7035
  • [3] An efficient method for simultaneous isolation of biologically active transcription factors and DNA
    Caruccio, L
    Banerjee, R
    [J]. JOURNAL OF IMMUNOLOGICAL METHODS, 1999, 230 (1-2) : 1 - 10
  • [4] A PPARγ-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis
    Chawla, A
    Boisvert, WA
    Lee, CH
    Laffitte, BA
    Barak, Y
    Joseph, SB
    Liao, D
    Nagy, L
    Edwards, PA
    Curtiss, LK
    Evans, RM
    Tontonoz, P
    [J]. MOLECULAR CELL, 2001, 7 (01) : 161 - 171
  • [5] Reduction of atherosclerosis in apolipoprotein E knockout mice by activation of the retinoid X receptor
    Claudel, T
    Leibowitz, MD
    Fiévet, C
    Tailleux, A
    Wagner, B
    Repa, JJ
    Torpier, G
    Lobaccaro, JM
    Paterniti, JR
    Mangelsdorf, DJ
    Heyman, RA
    Auwerx, J
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (05) : 2610 - 2615
  • [6] Liver X receptor activators display anti-inflammatory activity in irritant and allergic contact dermatitis models: Liver-X-receptor-specific inhibition of inflammation and primary cytokine production
    Fowler, AJ
    Sheu, MY
    Schmuth, M
    Kao, J
    Fluhr, JW
    Rhein, L
    Collins, JL
    Willson, TM
    Mangelsdorf, DJ
    Elias, PM
    Feingold, KR
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2003, 120 (02) : 246 - 255
  • [7] GOLDSTEIN JL, 1983, METHOD ENZYMOL, V98, P241
  • [8] Jiang Shuying, 2003, Nucl Recept, V1, P5, DOI 10.1186/1478-1336-1-5
  • [9] Reciprocal regulation of inflammation and lipid metabolism by liver X receptors
    Joseph, SB
    Castrillo, A
    Laffitte, BA
    Mangelsdorf, DJ
    Tontonoz, P
    [J]. NATURE MEDICINE, 2003, 9 (02) : 213 - 219
  • [10] Synthetic LXR ligand inhibits the development of atherosclerosis in mice
    Joseph, SB
    McKilligin, E
    Pei, LM
    Watson, MA
    Collins, AR
    Laffitte, BA
    Chen, MY
    Noh, G
    Goodman, J
    Hagger, GN
    Tran, J
    Tippin, TK
    Wang, XP
    Lusis, AJ
    Hsueh, WA
    Law, RE
    Collins, JL
    Willson, TM
    Tontonoz, P
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (11) : 7604 - 7609